European Journal of Molecular & Clinical Medicine

Abstract

The therapy of intertrochanteric fractures in older patients presents a
significant problem for today's orthopaedic surgeons. Extramedullary implants, such as
dynamic hip screws, have given way to intramedullary implants, such as PFNA2 nail
types. This represents an evolution in the implants. Early mobilisation of the patient is
the primary objective of treating such fractures, which almost never result in
complications such as non-union. This is done to avoid the consequences that can arise
from being bedridden for an extended period of time.
Materials and procedures: From 2015 and 2020, the current study comprised a total of
100 different patients. The PFNA and PFNA2 nails treatment was administered to a
total of 50 individuals. Current study took note of patients' ages and sexes, as well as the
nature of their injuries, any concomitant ailments, and any comorbidity. There was a
classification of fracture patterns.
Results: When compared to the PFNA implant, our findings showed that the PFNA2
procedure resulted in reduced intraoperative blood loss and improved outcomes with
regard to the rates of nonunion.
Conclusion: The PFNA2 implant is superior to other options in terms of the
intraoperative issues it causes, the amount of blood it requires, and the union rates it
achieves.